glp 1 nutrient deficiency Dietary intake by patients taking GLP-1 and dual GIP/GLP-1 receptor agonists: A narrative review and discussion of research needs The Shocking Truth about GLP-1s

PubMed PMID: 21975647 Comparative gastrointestinal adverse effects of GLP-1 receptor agonists and multi-target analogs in type 2 diabetes: a Bayesian network meta-analysis

Clinical trials show that Tirzepatide can lead to substantial weight loss, with some individuals experiencing a reduction of over 20% of their initial body weight

The resulting weight lossoften 15-20% of body weight with higher doses approved for obesity (Wegovy/Zepbound) and 5-10% with lower doses for diabetes (Ozempic/Mounjaro)can actually improve several cardiovascular risk factors

Since this procedure is more involved than a simple injectable, using the bodys natural processes and plasma from your own body, it is more expensive

GHK-Cu is being studied for its ability to support brain health and nervous system repair

Behavioral outcome measures to improve experimental stroke research